Dynatronics Corp. (DYNT)
Dynatronics Corp. (DYNT)
Vaxart Inc (VXRT)
Eyenovia Inc. (EYEN)
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
CareCloud Inc (CCLD)
CareCloud Joins Russell Microcap Index as Common Stock Price Rises 70% During Q2 2025
VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
Abeona Therapeutics Inc. (ABEO)
New Form 8-K - ABEONA THERAPEUTICS INC. Filed: 2025-07-02 AccNo: 0001641172-25-017460 Size: 257 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Briacell Therapeutics Corp (BCTX)
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
Organon & Co. (OGN)
Organon & Co. - Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
Organon & Co. (OGN)
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain